Literature DB >> 3088205

Variable region sequences of murine IgM anti-IgG monoclonal autoantibodies (rheumatoid factors). A structural explanation for the high frequency of IgM anti-IgG B cells.

M J Shlomchik, D A Nemazee, V L Sato, J Van Snick, D A Carson, M G Weigert.   

Abstract

The nucleotide sequences of heavy and light chains from 10 monoclonal IgM anti-IgG1 (RF) antibodies were determined and reported here as translated amino acid sequences. Only three families of VK light chains were used in these antibodies: VK1 (two examples), VK8 (three examples), and VK19 (four examples). This represents a significant nonrandom selection of light chains. In contrast, all other variable region gene segments (i.e., VH, DH, JH, and JK) were used in a pattern consistent with random selection from the available pool of germline genes. In two cases, the same anti-IgG1 specificity was generated by a combination of very homologous light chains with unrelated heavy chains. We infer from this that the light chain is the segment used by these antibodies to bind IgG1. The nature of these sequences provides an explanation for the curious observation that as many as 15% of splenic B cells in normal mice may be expressing IgM anti-IgG; if, as our data suggest, certain light chains in combination with many different heavy chains can be used in assembling the anti-IgG specificity, then, because of combinatorial association in which the heavy chain is not relevant for specificity, the fraction of IgM-producing B cells expressing these light chains should approximate the fraction of B cells making IgM anti-IgG. We calculate, based on data presented in several other studies, that 5-17% of B cells express one of the VK types observed in monoclonal RF. This agrees well with estimates for the number of B cells making IgM anti-IgG. In addition, our findings could rule out other explanations of the high percentage of B cells making RF, such as constant stimulation by antigen or presence of numerous antigenic epitopes since it was shown that IgM anti-IgG1 antibodies are not somatically mutated and that they are structurally homogeneous. We aligned the VK sequences of the RF in hopes of finding some primary sequence homology between the represented VK families which might point to residues involved in the binding interaction. Although we found no such homology in the hypervariable regions, we did find significant and unexpected homology in the FR2 and FR3 of these light chains. We noted that these regions are exposed in the Ig structure and postulate that they may be involved in a unique type of binding interaction between two Ig family domains, i.e., VK binding to a constant region domain of IgG.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3088205      PMCID: PMC2188225          DOI: 10.1084/jem.164.2.407

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  70 in total

1.  Analysis of the repertoire of anti-NP antibodies in C57BL/6 mice by cell fusion. I. Characterization of antibody families in the primary and hyperimmune response.

Authors:  M Reth; G J Hämmerling; K Rajewsky
Journal:  Eur J Immunol       Date:  1978-06       Impact factor: 5.532

2.  Developmentally controlled expression of immunoglobulin VH genes.

Authors:  R M Perlmutter; J F Kearney; S P Chang; L E Hood
Journal:  Science       Date:  1985-03-29       Impact factor: 47.728

3.  Anti-immunoglobulin antibodies IV. Cross-reaction of anti-idiotypic antibodies specific for rabbit and murine anti-a1 allotype antibodies with Fc fragment of human immunoglobulins.

Authors:  C A Bona; B Goldberg; D Metzger; J Urbain; H G Kunkel
Journal:  Eur J Immunol       Date:  1984-06       Impact factor: 5.532

4.  Classification of mouse VK groups based on the partial amino acid sequence to the first invariant tryptophan: impact of 14 new sequences from IgG myeloma proteins.

Authors:  M Potter; J B Newell; S Rudikoff; E Haber
Journal:  Mol Immunol       Date:  1982-12       Impact factor: 4.407

5.  Sequence of the full-length immunoglobulin kappa-chain of mouse myeloma MPC 11.

Authors:  G P Smith
Journal:  Biochem J       Date:  1978-05-01       Impact factor: 3.857

6.  Rheumatoid factor-like immunoglobulin M protects previously uninfected rat pups and dams from Trypanosoma lewisi.

Authors:  A B Clarkson; G H Mellow
Journal:  Science       Date:  1981-10-09       Impact factor: 47.728

7.  Cross-idiotypic specificity among monoclonal IgM proteins with anti- -globulin activity.

Authors:  H G Kunkel; V Agnello; F G Joslin; R J Winchester; J D Capra
Journal:  J Exp Med       Date:  1973-02-01       Impact factor: 14.307

8.  Contribution of antigen-presenting cell major histocompatibility complex gene products to the specificity of antigen-induced T cell activation.

Authors:  E Heber-Katz; R H Schwartz; L A Matis; C Hannum; T Fairwell; E Appella; D Hansburg
Journal:  J Exp Med       Date:  1982-04-01       Impact factor: 14.307

9.  Induction of rheumatoid antibodies in the mouse. Regulated production of autoantibody in the secondary humoral response.

Authors:  D A Nemazee; V L Sato
Journal:  J Exp Med       Date:  1983-08-01       Impact factor: 14.307

10.  Determinants recognized by murine rheumatoid factors: molecular localization using a panel of mouse myeloma variant immunoglobulins.

Authors:  V Stassin; P G Coulie; B K Birshtein; D S Secher; J Van Snick
Journal:  J Exp Med       Date:  1983-11-01       Impact factor: 14.307

View more
  44 in total

1.  Initiation and processing of two kappa immunoglobulin germ line transcripts in mouse B cells.

Authors:  D J Martin; B G van Ness
Journal:  Mol Cell Biol       Date:  1990-05       Impact factor: 4.272

2.  Agonistic antibodies to Fas induce a breach in the endothelial lining of the liver and a breakdown in B cell tolerance.

Authors:  M M Newkirk; U Nowak; E Skamene; D Iera; J Desbarats
Journal:  Clin Exp Immunol       Date:  2007-02       Impact factor: 4.330

Review 3.  Regulation of lupus-related autoantibody production and clinical disease by Toll-like receptors.

Authors:  Sean R Christensen; Mark J Shlomchik
Journal:  Semin Immunol       Date:  2007-02-02       Impact factor: 11.130

4.  Origin of the autoreactive anti-type II collagen response. I. Frequency of specific and multispecific B cells in primed murine lymph nodes.

Authors:  R Holmdahl; M Andersson; A Tarkowski
Journal:  Immunology       Date:  1987-07       Impact factor: 7.397

5.  Molecular basis for expression of the A48 regulatory idiotope on antibodies encoded by immunoglobulin variable-region genes from various families.

Authors:  H Zaghouani; F A Bonilla; K Meek; C Bona
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

6.  Induction of high titers of anti-IgE by immunization of inbred mice with syngeneic IgE.

Authors:  S Haba; A Nisonoff
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

7.  Molecular characterization of the variable regions of a mouse polyreactive IgG2b antibody with rheumatoid factor activity.

Authors:  A Sequeira; S Avrameas; E Jouvin-Marche
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

Review 8.  B and T cell antigen receptor repertoires in lupus/arthritis murine models.

Authors:  A N Theofilopoulos; P A Singer; R Kofler; D H Kono; M A Duchosal; R S Balderas
Journal:  Springer Semin Immunopathol       Date:  1989

9.  Molecular mechanisms resulting in pathogenic anti-mouse erythrocyte antibodies in New Zealand black mice.

Authors:  B B Scott; S Sadigh; M Stow; R A Mageed; E M Andrew; R N Maini
Journal:  Clin Exp Immunol       Date:  1993-07       Impact factor: 4.330

10.  Immunoglobulin V(H) chain gene analysis of peripheral blood IgM-producing B cells in patients with Kawasaki disease.

Authors:  Hyun Hee Lee; In Ho Park; Jeon-Soo Shin; Jun Soo Shin; Dong Soo Kim
Journal:  Yonsei Med J       Date:  2009-08-19       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.